IDEXX Laboratories, Inc

IDEXX has its largest business in the United States, but it also sells broadly across international markets, especially in Europe, Canada, Australia, and New Zealand. The company markets companion animal diagnostics through direct sales in the U.S. and through direct sales plus distributors in selected countries abroad, which creates some exposure to distributor inventory swings and foreign exchange. Its software and imaging offerings are also concentrated in North America, Europe, Australia, and New Zealand, while water and livestock products are sold in the U.S., Canada, and other international markets.

The company depends on continued adoption of its diagnostics and software in a competitive companion-animal market, so execution risk is tied to product innovation, pricing, and customer retention. Supply chain disruption, tariffs, foreign exchange, distributor inventory swings, and cybersecurity or IT outages can all affect revenue timing and operating performance. Regulatory requirements and patent expirations are additional constraints, although management says patent expirations are not expected to be material.